Progress of new therapy for severe asthma
CSTR:
Author:
Affiliation:

(Department of Respiratory Diseases, Second Affiliated Hospital of Harbin Medical University, Harbin 150000, China)

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Inhaled corticosteroids (ICS) is the mainstay of therapy for persistent asthma. However, its effect in the treatment of severe asthma is limited. At present, several new therapies have been approved for the treatment of severe asthma, including long-acting anticholinergic drugs (LAMAs), bronchial thermoplasty, targeted therapy, biological agents and immunosuppressive agents. We gave a summarization in order to provide reference for clinicians.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 06,2017
  • Revised:February 04,2017
  • Adopted:
  • Online: July 25,2017
  • Published:
Article QR Code